We report 2 kidney transplant patients with acute hemorrhagic cystitis. Adenovirus type 11 was isolated in the urine of both patients and in 1 patient adenovirus type 37 was also isolated. Each developed macrohematuria with urgency, micturition pain, elevated fever and functional deterioration of the transplanted kidney possibly due to acute rejection. These symptoms and laboratory data suggesting renal impairment persisted for approximately 4 weeks after therapy for acute rejection had been started without any specific additional treatment for adenovirus. Serum creatinine levels returned to slightly higher values than before this episode. Histological findings of biopsy specimens from the transplanted kidney in 1 patient indicated that renal impairment was attributable to acute rejection. According to the clinical results of our cases, there were no remarkable differences between adenovirus type 11 infection with or without type 37 infection. Acute hemorrhagic cystitis caused by the adenovirus is an interesting complication after kidney transplantation, especially with regard to kidney impairment and treatment.

Keywords:
Hemorrhagic cystitis, Adenovirus type 11 infection, Adenovirus type 37 infection, Kidney impairment, Kidney transplantation
This content is only available via PDF.
© 1996 S. Karger AG, Basel
1996
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.